TABLE 2.

Associations of physical activity, cardiorespiratory fitness, and body composition with menopausal symptoms in the cross-sectional study (n = 298)

	Total symptoms		Somato-vegetative symptoms		Psychological symptoms		Urogenital symptoms
	B	95% CI	B	95% CI	B	95% CI	B	95% CI
ACC-PA (10 mg)	−0.16	−0.86 to 0.55	−0.23	−0.53 to 0.08	−0.05	−0.39 to 0.28	0.12	−0.15 to 0.39
SR-PA (MET-h/d)	−0.13	−0.27 to 0.02	−0.07c	−0.13 to −0.00	−0.03	−0.10 to 0.04	−0.02	−0.08 to 0.04
Predicted VO2max (l/min)a	1.08	−1.80 to 3.95	0.35	−0.90 to 1.60	0.27	−1.08 to 1.63	0.45	−0.64 to 1.54
Total body mass (kg)b	0.06c	0.01 to 0.12	0.03d	0.01 to 0.05	0.03c	0.00 to 0.05	0.01	−0.01 to 0.03
Body fat mass (kg)b	0.07c	0.01 to 0.14	0.04c	0.01 to 0.06	0.03c	0.00 to 0.06	0.01	−0.02 to 0.03
Lean body mass (kg)b	0.13	−0.03 to 0.30	0.05	−0.02 to 0.12	0.07	−0.01 to 0.15	0.02	−0.05 to 0.08

Multiple imputation was applied in the analyses. All models are adjusted with menopausal status, age, use of hormonal preparations, smoking, education, and alcohol consumption.

ACC-PA, accelerometer-measured physical activity mean amplitude deviation; mg, milligravity (0.00981 m/s²); SR-PA, self-reported physical activity; VO_2max, maximal oxygen consumption.

^aModel is additionally adjusted with lean body mass.

^bModel is additionally adjusted with body height.

^cP < 0.05

^dP < 0.01